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Abstract
Introduction:  Transmissible spongiform encephalopathies are a group of neurodegenerative
diseases of humans and animals. Genetic Creutzfeldt-Jakob diseases, in which mutations in the PRNP
gene predispose to disease by causing the expression of abnormal PrP protein, include familial
Creutzfeldt-Jakob disease, Gerstmann-Straussler-Scheinker syndrome and fatal familial insomnia.
Case presentation: A 47-year-old Han-Chinese woman was hospitalized with a 2-year history of
progressive dementia, tiredness, lethargy and mild difficulty in falling asleep. On neurological
examination, there was severe apathy, spontaneous myoclonus of the lower limbs, generalized
hyperreflexia and bilateral Babinski signs. A missense mutation (T to G) was identified at the
position of nt 341 in one PRNP allele, leading to a change from glycine (Gly) to valine (Val) at codon
114. PK-resistant PrPSc was detected in brain tissues by Western blotting and immunohistochemical
assays. Information on pedigree was collected notably by interviews with family members. A further
four suspected patients in five consecutive generations of the family have been identified. One of
them was hospitalized for progressive memory impairment at the age of 32. On examination, he
had impairment of memory, calculation and comprehension, mild ataxia of the limbs, tremor and a
left Babinski sign. He is still alive.
Conclusion: This family with G114V inherited prion disease is the first to be described in China
and represents the second family worldwide in which this mutation has been identified. Three
other suspected cases have been retrospectively identified in this family, and a further case with
suggestive clinical manifestations has been shown by gene sequencing to have the causal mutation.
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Introduction
Transmissible spongiform encephalopathies (TSEs) are a
group of neurodegenerative diseases of the central nerv-
ous system (CNS). The best known of human forms of
TSE, Creutzfeldt-Jakob diseases (CJD), are classified into
three subtypes, sporadic CJD (sCJD), iatrogenic CJD
(iCJD), and genetic or familial CJD (gCJD or fCJD) [1].
Hereditary forms of human TSE in which mutations in the
prion protein gene (PRNP) predispose to disease include
fCJD, Gerstmann-Sträussler-Scheinker syndrome (GSS)
and fatal familial insomnia (FFI) [2].
To date, about 55 mutations associated with or directly
linked to human TSEs have been identified [3]. Here we
report a Chinese family with a mutation at codon 114
(G114V) of the PRNP gene. The index case had clinical
features, electroencephalogram (EEG) and magnetic reso-
nance imaging (MRI) findings similar to sporadic CJD.
We also present data on four suspected cases of fCJD in
five consecutive generations of the family.
Case presentation
Clinical features
A 47-year-old Han-Chinese woman was hospitalized with
a 2-year history of progressive dementia, tiredness, leth-
argy and mild difficulty in falling asleep. The initial com-
plaint was tiredness and loss of sleep. Several months after
the onset, she developed difficulty in communication and
was unable to work. This was followed by a gradually pro-
gressive dementia and emotional lability. The family
described increased appetite, and complex visual halluci-
nations. About 17 months after onset, the patient was first
hospitalized and CSF 14-3-3 was negative at that time. On
this admission, the patient was bedridden. On neurologi-
cal examination there was severe apathy, spontaneous
myoclonus of the lower limbs, generalized hyperreflexia
and bilateral Babinski signs. An EEG displayed slow waves
at 5 to 6 Hz, which were marked bilaterally in the frontal
lobes and precentral regions. MRI of the brain showed
bilateral atrophy of the cerebellar cortex, brainstem and
cerebellum (Figure 1A and 1B). On diffusion weighted
imaging (DWI), there were high signals in the caudate
nucleus, the putamen and the periventricular regions (Fig-
ure 1C). Biochemistry of the cerebrospinal fluid (CSF)
was normal; however, CSF 14-3-3 protein was not per-
formed. One week later, the patient was discharged [from
hospital and she died at home about 75 days later at the
age of 47.
Epidemiologic data
Information on pedigree was obtained by interviews with
family members. A total of 49 family members (including
spouses) were retrospectively or directly investigated (Fig-
ure 2A). Thirty-three of the family members belonged to
the proband's mother's lineage and 14 belonged to her
uncle's (her mother's brother) lineage. The proband's
maternal grandmother was said to have died with similar
clinical symptoms. The proband's elder brother devel-
oped neurological symptoms at the age of 45 years and
died 1 year after the onset. Her elder sister presented with
similar clinical manifestations at age of 35 years and died
2 years after onset. The son of her first cousin (IV 2) had
(A and B) Magnetic resonance imaging, showing clear bilateral atrophy of cortex, brainstem and cerebellum Figure 1
(A and B) Magnetic resonance imaging, showing clear bilateral atrophy of cortex, brainstem and cerebellum. 
(C) Diffusion weighted imaging, displaying high signal in the caudate nucleus and putamen.
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(A) Pedigree of the G114V inherited prion disease family Figure 2
(A) Pedigree of the G114V inherited prion disease family. Affected patients are described in the text. Open square, 
male; open circle, female; filled square with arrow, proband case; square or circle with prolonged diagonal lines, deceased 
cases; square or circle with overstriking double diagonal lines, patients with neurologic signs according to medical records; 
square or circle with fine line, asymptomatic carriers with the G114V mutation; square or circle with dot, persons having been 
confirmed not carrying the G114V mutation. (B) PRNP sequencing showed a point mutation on one allele at position 114. The 
arrow indicates the position where both G and T were present.
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limited intellectual ability from childhood and discontin-
ued his education at grade 4 of elementary school. He was
hospitalized for investigation of progressive memory
impairment 2 years ago at the age of 32 years. On exami-
nation, he had impairment of memory, calculation and
comprehension, mild ataxia of the limbs, tremor and a
left Babinski sign. He is still alive.
PRNP analysis
Brain autopsy of the proband was performed shortly after
death with informed consent. Genomic DNA was
extracted from the brain using Qiagen's DNA purification
kit according to the manufacturer's instructions. The
PRNP open reading frame was amplified by polymerase
chain reaction (PCR) using a protocol and primers
described elsewhere [4]. The genotype at codon 129 of
PRNP was determined by digestion with the restriction
endonuclease Nsp I. Analysis of PRNP sequences was per-
formed by direct sequencing in a MacBAC sequencer
(Pharmacia, USA). A missense mutation (T to G) was
identified at the position of nt 341 in one PRNP allele,
leading to change from glycine (Gly) to valine (Val) at
codon 114 (Figure 2B). No other nucleotide exchange was
found in the rest of the PRNP sequence. Nsp I digestion
and direct sequencing of the amplified product revealed a
methionine homozygous genotype at codon 129 of
PRNP. To identify the distribution of this point-mutation
in the family, blood samples of five other family mem-
bers, including the son of her first cousin (IV 2), were col-
lected and the PRNP genes were sequenced. As suspected,
the same G114V mutation was observed in the PRNP gene
of IV 2. In addition, two other health family members, the
proband's daughter (IV 10, age of 22) and the mother of
the second case (III 1, age of 61), were found to have the
same missense mutation. The son of the proband case (IV
9, age of 24) and the son of IV 2 (V 3, age of 9) were con-
firmed to have a wild-type PRNP sequence without such
mutation. All tested family members were homozygous
for methionine (M/M) at codon 129 of PRNP as in the
profile of Han Chinese [5].
Proteinase K (PK)-resistant PrP assays
Western blotting was performed to identify the presence
of PrPSc in the brain tissue of the patient. The brain tissue
sample was homogenized in 9 volumes of lysis buffer
(100 mM NaCl, 10 mM EDTA, 0.5% Nonidet P-40, 0.5%
sodium deoxycholate, 10 mM Tris, pH 7.5) according to
the protocol described elsewhere [6]. An aliquot of the
homogenate from cerebrum was incubated with PK (at a
final concentration at 50 μg/ml) at 37°C for 1 hour. Three
PK-resistant PrPSc bands ranging from Mr 21 to 27 kDa
were detected with predominance of monoglycosylated
PrPSc indicating type 1 PrPSc (Figure 3A). To examine the
distribution of PrPSc in different brain regions, aliquots of
10% tissue homogenates were prepared from various
brain regions and analyzed by Western blot. PK-resistant
PrP was detected in the midbrain, thalamus, cerebellum,
frontal lobe, temporal lobe, parietal lobe and occipital
lobe, but not in the medulla oblongata, pons or corpus
callosum. These findings seemed to be closely related to
the level of the total PrP signal before PK-digestion in each
homogenate (Figure 3A). The electrophoretic pattern of
PrPSc was the same in all preparations, with predominance
of monoglycosylated PrPSc.
Histological and immunohistochemical (IHC) assays
Paraffin sections of occipital lobe (5 μm in thickness)
were subjected to conventional staining with hematoxylin
and eosin (HE) and severe and extensive vacuolation was
identified in the tested tissues (Figure 3B). To identify
PrPSc in brain tissues, slices of occipital lobe were immu-
nostained using a protocol described elsewhere [7].
Briefly, the slices were treated with 4 M guanidine hydro-
chloride (GdnHCl) at 4°C for 90 minutes, followed by
microwave irradiation in distilled water for 25 minutes.
The slices were exposed to the PrP-specific monoclonal
antibody 3F4 at a dilution of 1:500 overnight at 4°C. For
visualization of immunostaining, the slices were devel-
oped with a commercial ready-to-use system (Beijing
Zhongshan Golden Bridge Biotechnology, China). The
slices were counterstained with hematoxylin, dehydrated,
and mounted in glycerolvinyl alcohol. Positive PrPSc
immunoblots were found in many of the tested tissues,
especially in the region of the gray matter. The deposits of
PrPSc were restricted mostly to the neuronal cytoplasm.
No obvious PrPSc deposits were observed in extracellular
areas (Figure 3B).
Conclusion
This family with G114V inherited prion disease is the first
to be described in China and represents the second family
worldwide in which this mutation has been identified.
The patient presented with clinical features similar to spo-
radic CJD, including a progressive neuropsychiatric dis-
turbance, dementia, myoclonus and pyramidal signs.
Cerebellar signs were observed relatively later, but became
marked. MRI revealed findings consistent with those often
seen in sporadic CJD, but the EEG did not show the typi-
cal periodic complexes of sporadic CJD. The CSF 14-3-3
was negative 1 year after onset. Typical spongiform degen-
eration and PrPSc deposits were observed in the brain and
Type-I PrPSc was detected in various brain regions. Three
other suspected cases have been retrospectively identified
in this family, and a further case with suggestive clinical
manifestations has been shown to have the causal muta-
tion by gene sequencing. The age at clinical onset in this
pedigree ranges from 32 to 45 years, which is somewhat
later than cases in a Uruguayan family [3], which was the
first to be described with a G114V mutation. However, the
duration of illness and other clinical manifestations areJournal of Medical Case Reports 2008, 2:331 http://www.jmedicalcasereports.com/content/2/1/331
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(A) Western blotting analysis of brain tissue from the proband Figure 3
(A) Western blotting analysis of brain tissue from the proband. Brain samples are treated with Proteinase K (+) at a 
concentration of 50 μg/ml or without Proteinase K (-) before electrophoresis. (Top) Western blot of brain homogenates with-
out Proteinase K digestion. (Bottom) Western blot graph of brain homogenates with Proteinase K digestion. Each brain region 
is indicated at the bottom of the image. Molecular weight standards are shown on the right. (B). Neuropathological assays of 
occipital lobe. Hematoxylin and eosin staining (left) and immunohistochemistry with monoclonal antibody 3F4 (right) (×400).
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quite similar in the two families. Interestingly, in our ped-
igree, the mother (III 1) of the second case carries the
G114V mutation in her PRNP gene and remains healthy
at the age of 61 years. This suggests that some other
unknown factors may influence the phenotype of genetic
human TSE.
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